Dr. Alan M. Rapoport
Dr. Alan M. Rapoport is a Clinical Professor of Neurology at The David Geffen School of Medicine at UCLA, Los Angeles, California, where he teaches medical students, neurology residents and fellows.
He is a Past President of the International Headache Society (IHS) and the founder and Director-Emeritus of The New England Center for Headache, in Stamford, Connecticut. Board-certified in Neurology and Headache Medicine, he has co-authored more than 300 articles, chapters and posters on headache and other neurological diseases. He has lectured around the country and internationally to general physicians and headache specialists on all aspects of headache pathophysiology, diagnosis and treatment and has appeared many times on national radio and television programs, such as Today and Good Morning America.
He is an editor of Headache, CNS Drugs and Editor in Chief of Neurology Reviews. He reviews for many peer-reviewed journals such as Cephalalgia, Neurology, New England Journal of Medicine and Headache.
He has co-authored nine books on headache for patients, physicians, and nurses with Drs. Fred Sheftell and Stewart Tepper.
He is the Co-Founder and CEO of BonTriage, an IT company in Silicon Valley, California, dedicated to helping patients and doctors around the globe by collecting detailed patient histories on line and linking with an app that monitors patient progress and outcomes. The company has started with headache and is moving into sleep, depression, anxiety, chronic pain and other areas. BonTriage just launched a headache app on Apple to track headache and medications.
Dr. Rapoport has served on the Board of Directors of the American Headache Society (AHS) and is the immediate past President of the Fairfield County Neurological Society (Connecticut), the Founding President of the Headache Cooperative of New England (HCNE), the Founding Director of the Headache Cooperative of the Pacific (HCOP) and until June 2011 was the Chairman of the Education and Membership Committee of the International Headache Society (IHS).